State of Alaska Department of Revenue decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 37.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,216 shares of the company’s stock after selling 8,524 shares during the quarter. State of Alaska Department of Revenue’s holdings in Henry Schein were worth $983,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Clarkston Capital Partners LLC lifted its position in Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares during the last quarter. Nuance Investments LLC lifted its position in Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Henry Schein during the third quarter valued at $515,000. Olstein Capital Management L.P. lifted its position in Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares during the last quarter. Finally, Thrivent Financial for Lutherans lifted its position in Henry Schein by 1,848.9% during the third quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after purchasing an additional 100,006 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Finally, Barrington Research lifted their price target on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Seven analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $80.10.
Henry Schein Price Performance
Henry Schein stock opened at $77.62 on Friday. The stock has a market cap of $9.68 billion, a price-to-earnings ratio of 31.94, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The firm has a 50-day moving average of $73.85 and a two-hundred day moving average of $71.93.
Insider Buying and Selling at Henry Schein
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.14% of the stock is owned by corporate insiders.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- High Flyers: 3 Natural Gas Stocks for March 2022
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Calculate Options Profits
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 10 Best Airline Stocks to Buy
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.